Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately
healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.
Last reviewed: February 2014
These trusted information partners have more on this topic.
Found 533 results
If your doctor suspects that you have anaemia (too few red blood cells), polycythaemia (too many red blood cells), or dehydration
Read more on Lab Tests Online website
Either to help differentiate between polycythaemia vera and secondary polycythaemia or to help differentiate between different types of anaemia and to determine whether the amount of erythropoietin being produced is appropriate for the level of anaemia present
Read more on Lab Tests Online website
An introduction to information on haemophilia, von Willebrand Disorder and related bleeding disorders and related information on hepatitis C and HIV.
Read more on Haemophilia Foundation Australia website
Vepesid Capsules - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Read more on Sydney Children's Hospitals Network website
Polycythaemia vera is a condition where the body makes too many red blood cells. Find out about the symptoms, causes, complications and treatment.
Read more on myDr website
Information about von Willebrand disorder or disease (VWD), how common it is, how it is passed on, inheritance and treatment.
Read more on Haemophilia Foundation Australia website
Information about the key issues for living with von Willebrand disease for females. Symptoms include heavy and painful periods. This explains how VWD is treated; how things might change over a lifetime, through puberty, childbirth and menopause; and how to manage health care.
Read more on Haemophilia Foundation Australia website
A quick overview of facts about haemophilia and von Willebrand disorder (or disease), including how many people have the condition, types of haemophilia, symptoms, treatment and inheritance.
Read more on Haemophilia Foundation Australia website
An introduction to information on haemophilia, von Willebrand Disorder and related bleeding disorders and related information on hepatitis C and HIV.
Read more on Haemophilia Foundation Australia website
Found 138 results
Hyperactive Janus kinase 2 signalling is a key molecular event in polycythaemia, essential thrombocythaemia and myelofibrosis. This is associated with the...
Read more on Australian Prescriber website
Renal colic pain is extremely painful and requires immediate treatment with strong analgesics. Dipyrone is a non-opioid analgesic widely used for this purpose but not licensed in some countries (e.g., USA, UK) because of potentially fatal side effects (agranulocytosis). This review aimed to assess the effectiveness and safety of single dose dipyrone in adults with moderate/severe renal colic pain but there were too few data to obtain clear results. The data available indicated that intravenous dipyrone was more effective than intramuscular dipyrone, and combining dipyrone with antispasmolytic agents did not improve its efficacy. Commonly reported side effects included dry mouth and drowsiness, and some patients experienced pain at the injection site. Agranulocytosis was not reported.
Read more on Cochrane (Australasian Centre) website
Antiplatelet drugs for preventing arterial and venous thrombotic events in patients with polycythaemia vera or essential thrombocythaemia
Read more on Cochrane (Australasian Centre) website
Read more on Cochrane (Australasian Centre) website
Haematologicalinterventions for treating disseminated intravascular coagulation during pregnancy and postpartum
Read more on Cochrane (Australasian Centre) website
We reviewed the clinical benefits and harms of anticoagulant and antifibrinolytic therapy for treating disseminated intravascular coagulation (DIC) in patients with acute or chronic leukemia.
Read more on Cochrane (Australasian Centre) website
Thalassaemia is a group of genetic blood disorders. Blood transfusion is needed to treat severe forms of the condition, but this results in a high level of iron in the body. This excess iron is usually removed by drugs through 'chelation therapy'. Other less usual treatments are bone marrow transplantation, which is restricted by age, and hydroxyurea, a drug designed to raise the level of foetal haemoglobin and reduce anaemia. Psychological support would seem suitable to manage thalassaemia which is a chronic disease with a considerable role for self-management. We were not able to find any trials to include in this review. There are some reports that teaching people about their condition improves adherence to chelation therapy. However, from the information currently available, we can not recommend the use of specific psychological therapies in thalassaemia. We believe there is a need for large trials to assess the value of psychological therapies for thalassaemia.
Read more on Cochrane (Australasian Centre) website
Read more on Cochrane (Australasian Centre) website
We reviewed the evidence about the effect of rituximab for treating people with acquired haemophilia A.
Read more on Cochrane (Australasian Centre) website
Regular clotting factor replacement therapy to prevent joint disease in people with severe hemophilia A or B
Read more on Cochrane (Australasian Centre) website
24 hour health advice and information you can count on
We are a government-funded service, providing quality, approved health information
